Correction to: Glutamine Antagonist JHU083 Normalizes Aberrant Glutamate Production and Cognitive Deficits in the EcoHIV Murine Model of HIV-Associated Neurocognitive Disorders.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Works matching IS 15571890 AND DT 2021 AND VI 16 AND IP 3
Results: 15
1
2
Society on NeuroImmune Pharmacology COVID-19 Virtual Workshop.
- Published in:
- 2021
- By:
- Publication type:
- Calendar
3
Can FDA-Approved Immunomodulatory Drugs be Repurposed/Repositioned to Alleviate Chronic Pain?
- Published in:
- Journal of NeuroImmune Pharmacology, 2021, v. 16, n. 3, p. 531, doi. 10.1007/s11481-021-10000-z
- By:
- Publication type:
- Article
4
Coronavirus Disease-19 Vaccines Best Reflect Effective Pharmaceuticals.
- Published in:
- 2021
- By:
- Publication type:
- Letter
5
The Symptoms and Clinical Manifestations Observed in COVID-19 Patients/Long COVID-19 Symptoms that Parallel Toxoplasma gondii Infections.
- Published in:
- 2021
- By:
- Publication type:
- Letter
6
Kynurenic Acid Protects Against Reactive Glial-associated Reductions in the Complexity of Primary Cortical Neurons.
- Published in:
- Journal of NeuroImmune Pharmacology, 2021, v. 16, n. 3, p. 679, doi. 10.1007/s11481-020-09976-x
- By:
- Publication type:
- Article
7
Brain Selective Estrogen Treatment Protects Dopaminergic Neurons and Preserves Behavioral Function in MPTP-induced Mouse Model of Parkinson's Disease.
- Published in:
- Journal of NeuroImmune Pharmacology, 2021, v. 16, n. 3, p. 667, doi. 10.1007/s11481-020-09972-1
- By:
- Publication type:
- Article
8
IMT504 Provides Analgesia by Modulating Cell Infiltrate and Inflammatory Milieu in a Chronic Pain Model.
- Published in:
- Journal of NeuroImmune Pharmacology, 2021, v. 16, n. 3, p. 651, doi. 10.1007/s11481-020-09971-2
- By:
- Publication type:
- Article
9
An Investigation into Proteomic Constituents of Cerebrospinal Fluid in Patients with Chronic Peripheral Neuropathic Pain Medicated with Opioids- a Pilot Study.
- Published in:
- Journal of NeuroImmune Pharmacology, 2021, v. 16, n. 3, p. 634, doi. 10.1007/s11481-020-09970-3
- By:
- Publication type:
- Article
10
Human Amniotic Epithelial Cells Alleviate a Mouse Model of Parkinson's Disease Mainly by Neuroprotective, Anti-Oxidative and Anti-Inflammatory Factors.
- Published in:
- Journal of NeuroImmune Pharmacology, 2021, v. 16, n. 3, p. 620, doi. 10.1007/s11481-020-09969-w
- By:
- Publication type:
- Article
11
Reduction of Lewy Body Pathology by Oral Cinnamon.
- Published in:
- Journal of NeuroImmune Pharmacology, 2021, v. 16, n. 3, p. 592, doi. 10.1007/s11481-020-09955-2
- By:
- Publication type:
- Article
12
Astaxanthin Improved the Cognitive Deficits in APP/PS1 Transgenic Mice Via Selective Activation of mTOR.
- Published in:
- Journal of NeuroImmune Pharmacology, 2021, v. 16, n. 3, p. 609, doi. 10.1007/s11481-020-09953-4
- By:
- Publication type:
- Article
13
Social Environment Ameliorates Behavioral and Immune Impairments in Tyrosine Hydroxylase Haploinsufficient Female Mice.
- Published in:
- Journal of NeuroImmune Pharmacology, 2021, v. 16, n. 3, p. 548, doi. 10.1007/s11481-020-09947-2
- By:
- Publication type:
- Article
14
Reactive Oxygen Species (ROS) are Critical for Morphine Exacerbation of HIV-1 gp120-Induced Pain.
- Published in:
- Journal of NeuroImmune Pharmacology, 2021, v. 16, n. 3, p. 581, doi. 10.1007/s11481-020-09951-6
- By:
- Publication type:
- Article
15
Antibodies from Multiple Sclerosis Brain Identified Epstein-Barr Virus Nuclear Antigen 1 & 2 Epitopes which Are Recognized by Oligoclonal Bands.
- Published in:
- Journal of NeuroImmune Pharmacology, 2021, v. 16, n. 3, p. 567, doi. 10.1007/s11481-020-09948-1
- By:
- Publication type:
- Article